These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34467805)

  • 1. Oral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination.
    Hack B; Timalsina U; Tefera E; Wilkerson B; Paku E; Fernandez S; Fishbein D
    J Prim Care Community Health; 2021; 12():21501327211034379. PubMed ID: 34467805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial.
    Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Cody O; Maus A; Shah DV; Westergaard RP
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e23080. PubMed ID: 33616545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use.
    Spaderna M; Kattakuzhy S; Kang SJ; George N; Bijole P; Ebah E; Eyasu R; Ogbumbadiugha O; Silk R; Gannon C; Davis A; Cover A; Gayle B; Narayanan S; Pao M; Kottilil S; Rosenthal E
    Int J Drug Policy; 2023 Jan; 111():103906. PubMed ID: 36384062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.
    Evans ME; Person M; Reilley B; Leston J; Haverkate R; McCollum JT; Apostolou A; Bohm MK; Van Handel M; Bixler D; Mitsch AJ; Haberling DL; Hatcher SM; Weiser T; Elmore K; Teshale EH; Weidle PJ; Peters PJ; Buchacz K
    Public Health Rep; 2020; 135(4):461-471. PubMed ID: 32633599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
    Assoumou SA; Wang J; Nolen S; Eftekhari Yazdi G; Mayer KH; Puro J; Salomon JA; Linas BP
    J Gen Intern Med; 2020 May; 35(5):1477-1483. PubMed ID: 32133577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
    Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
    Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
    [No Abstract]   [Full Text] [Related]  

  • 8. Sociodemographic characteristics associated with hepatitis C among patients admitted for medically managed opioid withdrawal in east Tennessee.
    Alexander R; Agboola O; Costales V
    J Addict Dis; 2022; 40(1):92-95. PubMed ID: 34121634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.
    Tsui JI; Akosile MA; Lapham GT; Boudreau DM; Johnson EA; Bobb JF; Binswanger IA; Yarborough BJH; Glass JE; Rossom RC; Murphy MT; Cunningham CO; Arnsten JH; Thakral M; Saxon AJ; Merrill JO; Samet JH; Bart GB; Campbell CI; Loree AM; Silva A; Stotts AL; Ahmedani B; Braciszewski JM; Hechter RC; Northrup TF; Horigian VE; Bradley KA
    J Gen Intern Med; 2021 Apr; 36(4):930-937. PubMed ID: 33569735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
    Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
    Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
    PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Opioid Use Disorder After Breast Reconstruction: Effects of Nicotine Exposure.
    Groff D; Freedman Z; Gilles A; Bone C; Johnson TS
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S241-S244. PubMed ID: 38556681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.
    Page K; Leeman L; Bishop S; Cano S; Bakhireva LN
    Matern Child Health J; 2017 Sep; 21(9):1778-1783. PubMed ID: 28699096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New hepatitis C diagnoses in Ontario, Canada are associated with the local prescription patterns of a controlled-release opioid.
    Meyer M; Bondy L; Koivu S; Koval J; Scarffe AD; Silverman MS
    J Viral Hepat; 2020 Aug; 27(8):774-780. PubMed ID: 32187428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
    Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
    Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion.
    Wilton J; Wong S; Purssell R; Abdia Y; Chong M; Karim ME; MacInnes A; Bartlett SR; Balshaw RF; Gomes T; Yu A; Alvarez M; Dart RC; Krajden M; Buxton JA; Janjua NZ
    JAMA Netw Open; 2022 Jan; 5(1):e2143050. PubMed ID: 35019983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study.
    Krans EE; Zickmund SL; Rustgi VK; Park SY; Dunn SL; Schwarz EB
    Subst Abus; 2016; 37(1):88-95. PubMed ID: 26569631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection.
    Eller AJ; DiDomizio EE; Madden LM; Oliva JD; Altice FL; Johnson KA
    Ann Med; 2022 Dec; 54(1):1714-1724. PubMed ID: 35775786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Knowledge Among Pregnant Women with Opioid Use Disorder.
    Krans EE; Rothenberger SD; Morrison PK; Park SY; Klocke LC; Turocy MJ; Zickmund S
    Matern Child Health J; 2018 Aug; 22(8):1208-1216. PubMed ID: 29500784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.